The France cardiovascular ultrasound market was valued at $162.97 million in 2020, and is projected to reach $252.90 million by 2030, registering a CAGR of 4.7% from 2021 to 2030.
Cardiac ultrasound, or echocardiography, is a non-invasive diagnostic modality that can provide detailed hemodynamic information in a short period of time at a patient's bedside. Cardiac ultrasound should be performed with a low-frequency probe that has a small footprint that can fit between the ribs, using a cardiac setting. It is a non-invasive, rapid, and inexpensive application that expedites diagnosis and management of imminently life-threatening diseases, including pericardial tamponade, acute coronary syndrome, cardiomyopathy, pulmonary embolism, and Stanford type-A aortic dissection. It can also differentiate shock states and guide resuscitative measures. It must be performed by inter-professional team and nurses should be prepared to assist the provider in point-of-care ultrasound applications.
The key factors that boost the growth of the France cardiovascular ultrasound market include increased advantages of echocardiography over invasive cardiac diagnostic procedures and increase in incidence of cardiovascular diseases (CVDs). In addition, this technology is widely accepted among patients as it is non-invasive, hence shortens the stay at hospitals, which fuels the market growth. However, factors such as economic influence of approving new technologies and insufficient reimbursement scenario impede the growth of the market. Conversely, technological advancements leading in cardiac specific technologies such as tissue enhancements, lateral gain control, advanced dynamic flow, tissue Doppler, and stress echo provide lucrative opportunities for the growth of the market.
The France cardiovascular ultrasound market is segmented into clinical application, technology, device display, age group, and end user. On the basis of clinical application, the market is categorized into diagnostic cardiology, interventional cardiology, and vascular diagnostic. Diagnostic cardiology is further categorized as transthoracic echocardiogram, transesophageal echocardiogram, stress echocardiogram, and other echocardiogram. Interventional cardiology is further categorized as electrophysiology procedure, septal closure procedure and others. Vascular diagnostic is further categorized as aortoiliac duplex, carotid duplex, lower extremity arterial duplex, iliocaval duplex, and mesenteric duplex. By technology, it is classified into 2D, 3D & 4D, and Doppler imaging. By device display, it is classified into color display and black &white display. By age group, it is classified into adult and pediatric. By end user, it is classified into private clinics, public hospitals, cardiology centers, and ambulatory centers.
Cardiac ultrasound, or echocardiography, is a non-invasive diagnostic modality that can provide detailed hemodynamic information in a short period of time at a patient's bedside. Cardiac ultrasound should be performed with a low-frequency probe that has a small footprint that can fit between the ribs, using a cardiac setting. It is a non-invasive, rapid, and inexpensive application that expedites diagnosis and management of imminently life-threatening diseases, including pericardial tamponade, acute coronary syndrome, cardiomyopathy, pulmonary embolism, and Stanford type-A aortic dissection. It can also differentiate shock states and guide resuscitative measures. It must be performed by inter-professional team and nurses should be prepared to assist the provider in point-of-care ultrasound applications.
The key factors that boost the growth of the France cardiovascular ultrasound market include increased advantages of echocardiography over invasive cardiac diagnostic procedures and increase in incidence of cardiovascular diseases (CVDs). In addition, this technology is widely accepted among patients as it is non-invasive, hence shortens the stay at hospitals, which fuels the market growth. However, factors such as economic influence of approving new technologies and insufficient reimbursement scenario impede the growth of the market. Conversely, technological advancements leading in cardiac specific technologies such as tissue enhancements, lateral gain control, advanced dynamic flow, tissue Doppler, and stress echo provide lucrative opportunities for the growth of the market.
The France cardiovascular ultrasound market is segmented into clinical application, technology, device display, age group, and end user. On the basis of clinical application, the market is categorized into diagnostic cardiology, interventional cardiology, and vascular diagnostic. Diagnostic cardiology is further categorized as transthoracic echocardiogram, transesophageal echocardiogram, stress echocardiogram, and other echocardiogram. Interventional cardiology is further categorized as electrophysiology procedure, septal closure procedure and others. Vascular diagnostic is further categorized as aortoiliac duplex, carotid duplex, lower extremity arterial duplex, iliocaval duplex, and mesenteric duplex. By technology, it is classified into 2D, 3D & 4D, and Doppler imaging. By device display, it is classified into color display and black &white display. By age group, it is classified into adult and pediatric. By end user, it is classified into private clinics, public hospitals, cardiology centers, and ambulatory centers.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2030, which assists to identify the prevailing market opportunities.
- An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
- A comprehensive analysis of the factors that drive and restrain the growth of the France cardiovascular ultrasound market is provided.
- An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
KEY MARKET SEGMENTS
By Clinical Application
- Diagnostic Cardiology
- Transthoracic Echocardiogram
- Transesophageal Echocardiogram
- Stress Echocardiogram
- Other Echocardiogram
- Interventional Cardiology
- Electrophysiology Procedure
- Septal Closure Procedure
- Others
- Vascular Diagnostics
- Aortoiliac Duplex,
- Carotid Duplex,
- Lower Extremity Arterial Duplex,
- Iliocaval Duplex
- Mesenteric Duplex
By Technology
- 2D
- 3D & 4D
- Doppler Imaging
By Device Display
- Colour Display
- Black and White Display
By Age Group
- Adult
- Paediatric
By End User
- Private Clinics
- Diagnostic Cardiology
- Interventional Cardiology
- Vascular Diagnostics
- Public Hospitals
- Diagnostic Cardiology
- Interventional Cardiology
- Vascular Diagnostics
- Cardiology Centres
- Diagnostic Cardiology
- Interventional Cardiology
- Vascular Diagnostics
- Ambulatory Centres
- Diagnostic Cardiology
- Interventional Cardiology
- Vascular Diagnostics
KEY MARKET PLAYERS
- Canon Inc. (Canon Medical System Corporation)
- Esaote S.p.A
- Fujifilm Holding Corporation
- General Electric Company
- Hitachi Ltd
- Koninklijke Philips N.V.
- Mindray Medical International Limited
- Samsung Group
- Siemens AG
- SuperSonic Imagine
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET LANDSCAPE
CHAPTER 4: FRANCE CARDIOVASCULAR ULTRASOUND MARKET, BY CLINICAL APPLICATION
CHAPTER 5: FRANCE CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY
CHAPTER 6: FRANCE CARDIOVASCULAR ULTRASOUND MARKET, BY DEVICE DISPLAY
CHAPTER 7: FRANCE CARDIOVASCULAR ULTRASOUND MARKET, BY AGE GROUP
CHAPTER 8: FRANCE CARDIOVASCULAR ULTRASOUND MARKET, BY END USER
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Companies Mentioned
- Canon Inc. (Canon Medical System Corporation)
- Esaote S.p.A
- Fujifilm Holding Corporation
- General Electric Company
- Hitachi Ltd
- Koninklijke Philips N.V.
- Mindray Medical International Limited
- Samsung Group
- Siemens AG
- SuperSonic Imagine
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 173 |
| Published | December 2021 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 162.97 million |
| Forecasted Market Value ( USD | $ 252.9 million |
| Compound Annual Growth Rate | 4.5% |
| Regions Covered | France |
| No. of Companies Mentioned | 10 |
